Catalyst Pharmaceuticals (CPRX) Non-cash Items (2013 - 2025)
Catalyst Pharmaceuticals posted quarterly Non-cash Items of $7.1 million for Q4 2025, down 2.99% year-on-year from $7.4 million in Q4 2024, and down 2.99% on a QoQ basis from $7.4 million in Q4 2024.
Catalyst Pharmaceuticals (CPRX) has 8 years of Non-cash Items data on file, last reported at $7.1 million in Q4 2025.
- For the quarter ending Q4 2025, Non-cash Items fell 2.99% year-over-year to $7.1 million; the trailing twelve-month figure through Dec 2025 stood at $7.1 million (down 2.99% YoY), and the FY2025 full-year result was $7.1 million, down 2.99% from the prior year.
- Non-cash Items for Q4 2025 stood at $7.1 million, down from $7.4 million in the prior quarter.
- Across five years, Non-cash Items topped out at $7.4 million in Q4 2024 and bottomed at $7.1 million in Q4 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 7.13 Mn |
| Dec 31, 2025 | 7.13 Mn |
| Dec 31, 2024 | 7.35 Mn |
| Dec 31, 2024 | 7.35 Mn |
| Dec 31, 2018 | 4.35 Mn |
| Dec 31, 2018 | 4.35 Mn |
| Sep 30, 2018 | 4.01 Mn |
| Sep 30, 2018 | 4.01 Mn |
| Jun 30, 2018 | 4.10 Mn |
| Jun 30, 2018 | 4.10 Mn |
| Mar 31, 2018 | 3.62 Mn |
| Mar 31, 2018 | 3.62 Mn |
| Dec 31, 2017 | 2.91 Mn |
| Dec 31, 2017 | 2.91 Mn |
| Sep 30, 2017 | 3.50 Mn |
| Sep 30, 2017 | 3.50 Mn |
| Jun 30, 2017 | 3.24 Mn |
| Jun 30, 2017 | 3.24 Mn |
| Mar 31, 2017 | 2.64 Mn |
| Mar 31, 2017 | 2.64 Mn |
| Dec 31, 2016 | 2.39 Mn |
| Dec 31, 2016 | 2.39 Mn |
| Sep 30, 2016 | 2.45 Mn |
| Sep 30, 2016 | 2.45 Mn |
| Jun 30, 2016 | 2.21 Mn |
| Jun 30, 2016 | 2.21 Mn |
| Mar 31, 2016 | 2.03 Mn |
| Mar 31, 2016 | 2.03 Mn |
| Dec 31, 2015 | 2.04 Mn |
| Dec 31, 2015 | 2.04 Mn |
| Sep 30, 2015 | 2.06 Mn |
| Sep 30, 2015 | 2.06 Mn |
| Jun 30, 2015 | 1.95 Mn |
| Jun 30, 2015 | 1.95 Mn |
| Mar 31, 2015 | 1.88 Mn |
| Mar 31, 2015 | 1.88 Mn |
| Dec 31, 2014 | 2.69 Mn |
| Dec 31, 2014 | 2.69 Mn |
| Sep 30, 2014 | 3.23 Mn |
| Sep 30, 2014 | 3.23 Mn |
| Jun 30, 2014 | 3.10 Mn |
| Jun 30, 2014 | 3.10 Mn |
| Mar 31, 2014 | 3.09 Mn |
| Mar 31, 2014 | 3.09 Mn |
| Dec 31, 2013 | 3.09 Mn |
| Dec 31, 2013 | 3.09 Mn |
| Sep 30, 2013 | 2.81 Mn |
| Sep 30, 2013 | 2.81 Mn |
| Jun 30, 2013 | 2.83 Mn |
| Jun 30, 2013 | 2.83 Mn |